Literature DB >> 15778507

Pulmonary defense and the human cathelicidin hCAP-18/LL-37.

R J Fahy1, M D Wewers.   

Abstract

Antimicrobial peptides form an important component of the innate immune system. The cathelicidin family, a key member of the antimicrobial peptide defenses, has been highly conserved throughout evolution. Though widespread in mammals, there is currently only one identified human example, hCAP-18/LL-37. The cathelicidins have been found to have multiple functions, in addition to their known antimicrobial and lipopolysaccharide-neutralizing effects. As a result, they profoundly affect both innate and adaptive immunity. Currently, antimicrobial peptides are being evaluated as therapeutic drugs in disease states as diverse as oral mucositis, cystic fibrosis, and septic shock. One such peptide, the cathelicidin hCAP-18/LL-37, is reviewed in detail in the context of its role in lung physiology and defense.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778507      PMCID: PMC7102303          DOI: 10.1385/IR:31:2:075

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  82 in total

Review 1.  Plant disease resistance: commonality and novelty in multicellular innate immunity.

Authors:  R Fluhr; R N Kaplan-Levy
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family.

Authors:  W M Shafer; X Qu; A J Waring; R I Lehrer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells.

Authors:  F Niyonsaba; A Someya; M Hirata; H Ogawa; I Nagaoka
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

4.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.

Authors:  I Nagaoka; S Hirota; F Niyonsaba; M Hirata; Y Adachi; H Tamura; D Heumann
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 6.  Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors:  W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

7.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.

Authors:  O E Sørensen; P Follin; A H Johnsen; J Calafat; G S Tjabringa; P S Hiemstra; N Borregaard
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

8.  Expression of cathelicidin in human salivary glands.

Authors:  Jeong-Su Woo; Ji Yong Jeong; You Jin Hwang; Sung Won Chae; Soon Jae Hwang; Heung-Man Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-02

Review 9.  Current status of gene therapy for cystic fibrosis pulmonary disease.

Authors:  Mary Jayne Kennedy
Journal:  Am J Respir Med       Date:  2002

10.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

View more
  11 in total

1.  P2X(7) receptor and macrophage function.

Authors:  Mark D Wewers; Anasuya Sarkar
Journal:  Purinergic Signal       Date:  2009-02-13       Impact factor: 3.765

Review 2.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

3.  Antimicrobial Peptides in Innate Immunity against Mycobacteria.

Authors:  Dong-Min Shin; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2011-10-31       Impact factor: 6.303

Review 4.  With Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia.

Authors:  Roger D Pechous
Journal:  Front Cell Infect Microbiol       Date:  2017-05-01       Impact factor: 5.293

Review 5.  Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential.

Authors:  Philippe Md Potey; Adriano G Rossi; Christopher D Lucas; David A Dorward
Journal:  J Pathol       Date:  2019-02-15       Impact factor: 7.996

6.  Cathelicidin hCAP18/LL-37 promotes cell proliferation and suppresses antitumor activity of 1,25(OH)2D3 in hepatocellular carcinoma.

Authors:  Huidan Zhang; Junai Zhen; Rong Zhang; Yangke Wanyan; Kehang Liu; Xueli Yuan; Liping Tao; Yuqing Chen
Journal:  Cell Death Discov       Date:  2022-01-17

Review 7.  Cytotoxic and antitumor peptides as novel chemotherapeutics.

Authors:  Xin Luan; Ye Wu; Yi-Wen Shen; Hong Zhang; Yu-Dong Zhou; Hong-Zhuan Chen; Dale G Nagle; Wei-Dong Zhang
Journal:  Nat Prod Rep       Date:  2020-08-10       Impact factor: 15.111

Review 8.  Biofilms: an advancement in our understanding of Francisella species.

Authors:  Monique L van Hoek
Journal:  Virulence       Date:  2013-11-12       Impact factor: 5.882

9.  Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.

Authors:  Kajal Gupta; Sameer Singh; Monique L van Hoek
Journal:  Antibiotics (Basel)       Date:  2015-08-24

10.  Respiratory ß-2-Microglobulin exerts pH dependent antimicrobial activity.

Authors:  Armin Holch; Richard Bauer; Lia-Raluca Olari; Armando A Rodriguez; Ludger Ständker; Nico Preising; Merve Karacan; Sebastian Wiese; Paul Walther; Yasser B Ruiz-Blanco; Elsa Sanchez-Garcia; Christian Schumann; Jan Münch; Barbara Spellerberg
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.